Genomic-led AML Clinical Decision Making Within Seven Days
Audio Journal of Oncology
Reporting from 2018 annual meeting of the American Society of Hematology
SAN DIEGO—Individualized therapy decisions that are founded on “genomic fingerprint†data can now be made within seven days for most patients with suspected diagnoses of …